Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1998-03

AUTHORS

Hirofumi Hiyama, Antonio Iavarone, Steven A Reeves

ABSTRACT

The control of cell cycle progression is orchestrated by an extraordinary diverse and dynamic in function group of proteins. Critical in the progression are the actions of the E2F family of transcription factors which regulate the expression of genes necessary for the G1/S transition and the WAF/CIP/KIP family of cdk inhibitors which can inhibit cell cycle progression. In this report, we have identified E2F binding sites in both the human and mouse p21 promoters that bind E2F protein complexes from nuclear extracts in a cell cycle-dependent manner. In ectopic expression experiments we determined that E2F1, but not E2F4, can strongly transactivate the human p21 gene through these E2F binding sites which are located in the -215/+1 region of the p21 gene. The transactivation of the p21 gene through regulatory elements within the -215/+1 region of the promoter was correlated with increased levels of endogenous E2F1 and p21 proteins at the G1/S boundary. The significance of transactivation of the p21 gene by E2F is that p21 function is important in cell cycle progression as well as for cell cycle arrest. Indeed, E2F-induced levels of p21 protein during the G1/ S transition is consistent with the recent findings demonstrating that p21 acts as an assembly factor for kinase active cyclin/cdk/p21 complexes. More... »

PAGES

1201667

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.onc.1201667

DOI

http://dx.doi.org/10.1038/sj.onc.1201667

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1034122147

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9569018


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Binding Sites", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carrier Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Cycle", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Cycle Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclin-Dependent Kinase Inhibitor p21", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA-Binding Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "E2F Transcription Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "E2F1 Transcription Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "E2F4 Transcription Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "G1 Phase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Promoter Regions, Genetic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retinoblastoma-Binding Protein 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "S Phase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transcription Factor DP1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transcription Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Harvard University", 
          "id": "https://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Molecular Neuro-Oncology, Neuroscience Center, Neurosurgical Services, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02129, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hiyama", 
        "givenName": "Hirofumi", 
        "id": "sg:person.0752637635.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752637635.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Memorial Sloan Kettering Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Cell Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, NY, New York 10021, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iavarone", 
        "givenName": "Antonio", 
        "id": "sg:person.0743765737.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743765737.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Harvard University", 
          "id": "https://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Molecular Neuro-Oncology, Neuroscience Center, Neurosurgical Services, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02129, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reeves", 
        "givenName": "Steven A", 
        "id": "sg:person.01135201435.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135201435.94"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/b978-0-444-81382-4.50019-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035931085"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1998-03", 
    "datePublishedReg": "1998-03-01", 
    "description": "The control of cell cycle progression is orchestrated by an extraordinary diverse and dynamic in function group of proteins. Critical in the progression are the actions of the E2F family of transcription factors which regulate the expression of genes necessary for the G1/S transition and the WAF/CIP/KIP family of cdk inhibitors which can inhibit cell cycle progression. In this report, we have identified E2F binding sites in both the human and mouse p21 promoters that bind E2F protein complexes from nuclear extracts in a cell cycle-dependent manner. In ectopic expression experiments we determined that E2F1, but not E2F4, can strongly transactivate the human p21 gene through these E2F binding sites which are located in the -215/+1 region of the p21 gene. The transactivation of the p21 gene through regulatory elements within the -215/+1 region of the promoter was correlated with increased levels of endogenous E2F1 and p21 proteins at the G1/S boundary. The significance of transactivation of the p21 gene by E2F is that p21 function is important in cell cycle progression as well as for cell cycle arrest. Indeed, E2F-induced levels of p21 protein during the G1/ S transition is consistent with the recent findings demonstrating that p21 acts as an assembly factor for kinase active cyclin/cdk/p21 complexes.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.onc.1201667", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1097543", 
        "issn": [
          "0950-9232", 
          "1476-5594"
        ], 
        "name": "Oncogene", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F", 
    "pagination": "1201667", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a28c1fc673693cfc0c6a9d795dbe405baf6e925e80d98669434a17bbb9b38efa"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9569018"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8711562"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.onc.1201667"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1034122147"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.onc.1201667", 
      "https://app.dimensions.ai/details/publication/pub.1034122147"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000360_0000000360/records_118315_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.nature.com/articles/1201667"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1201667'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1201667'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1201667'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1201667'


 

This table displays all metadata directly associated to this object as RDF triples.

181 TRIPLES      21 PREDICATES      53 URIs      44 LITERALS      32 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.onc.1201667 schema:about N02d5b5b532a1418a8ace1acc369619b2
2 N19cbd125d8b3475eb015b8afeb71125a
3 N2b9c9d698af74ec29c44e1c702598c0f
4 N2ef516bf91da413abb3f95b8b8ceb97d
5 N3bce8b543b1948c6aa66f4ff565b44b9
6 N418e61a270194e57a07e1725017c0e28
7 N41c83773148b48389ed1bfa2f5a615cb
8 N4d80f5baa3ef441282b3a4c491d2f895
9 N53171f0c81814ad9a6e667c6f7a274f1
10 N81e95fd87b744da998938904f1cf712b
11 N897ded43a2c14da8a07252078bc254a4
12 N8d8a02b107724b2fab626d9b5ab94739
13 Na24f7a8b3ec64c768966fb0fc6848a28
14 Na67e758bf5c745c0b330d20c6b5028f7
15 Nb0fec11d379642148434b94118f39915
16 Nb561ace6fcb24e10bce5f4f762571664
17 Nc04627175af54d66938c8d071c2b2a0b
18 Nce31583126414be1bca9217afe08219d
19 Ndfa72609c77748b9989bf4e5735afca0
20 Ne04de28244454597bd06475be53a935c
21 Ne61ff0e05e5848b096dc1cf3661530e5
22 Ne900918f85c54389a0de30d361f1b240
23 Ne9826132589c4e2097cba73363f4a8a0
24 anzsrc-for:06
25 anzsrc-for:0601
26 schema:author Nb3d15c434b114d499f491d1aae0f52a1
27 schema:citation https://doi.org/10.1016/b978-0-444-81382-4.50019-0
28 schema:datePublished 1998-03
29 schema:datePublishedReg 1998-03-01
30 schema:description The control of cell cycle progression is orchestrated by an extraordinary diverse and dynamic in function group of proteins. Critical in the progression are the actions of the E2F family of transcription factors which regulate the expression of genes necessary for the G1/S transition and the WAF/CIP/KIP family of cdk inhibitors which can inhibit cell cycle progression. In this report, we have identified E2F binding sites in both the human and mouse p21 promoters that bind E2F protein complexes from nuclear extracts in a cell cycle-dependent manner. In ectopic expression experiments we determined that E2F1, but not E2F4, can strongly transactivate the human p21 gene through these E2F binding sites which are located in the -215/+1 region of the p21 gene. The transactivation of the p21 gene through regulatory elements within the -215/+1 region of the promoter was correlated with increased levels of endogenous E2F1 and p21 proteins at the G1/S boundary. The significance of transactivation of the p21 gene by E2F is that p21 function is important in cell cycle progression as well as for cell cycle arrest. Indeed, E2F-induced levels of p21 protein during the G1/ S transition is consistent with the recent findings demonstrating that p21 acts as an assembly factor for kinase active cyclin/cdk/p21 complexes.
31 schema:genre research_article
32 schema:inLanguage en
33 schema:isAccessibleForFree true
34 schema:isPartOf N46f478dd03cf40a989a67bc17cbdbcda
35 N893880fb3caa46d4bf97a813cf921577
36 sg:journal.1097543
37 schema:name Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F
38 schema:pagination 1201667
39 schema:productId N283c078b12b94ea38622a73e53f6c06d
40 N5231231e32e242889fd6f3a338dae72d
41 N5eaa8c60e8ab4b73b4b5381917d46d49
42 N5f65e69ab18e41ca807ee21d80484e71
43 Nc656112d19c64e7ab9cd2ebc93045a24
44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034122147
45 https://doi.org/10.1038/sj.onc.1201667
46 schema:sdDatePublished 2019-04-11T12:04
47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
48 schema:sdPublisher Nd7d9537aebaa4f569172545081926da3
49 schema:url http://www.nature.com/articles/1201667
50 sgo:license sg:explorer/license/
51 sgo:sdDataset articles
52 rdf:type schema:ScholarlyArticle
53 N02d5b5b532a1418a8ace1acc369619b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
54 schema:name E2F1 Transcription Factor
55 rdf:type schema:DefinedTerm
56 N19cbd125d8b3475eb015b8afeb71125a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
57 schema:name Tumor Cells, Cultured
58 rdf:type schema:DefinedTerm
59 N283c078b12b94ea38622a73e53f6c06d schema:name pubmed_id
60 schema:value 9569018
61 rdf:type schema:PropertyValue
62 N2b9c9d698af74ec29c44e1c702598c0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Transcription Factors
64 rdf:type schema:DefinedTerm
65 N2ef516bf91da413abb3f95b8b8ceb97d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Animals
67 rdf:type schema:DefinedTerm
68 N3bce8b543b1948c6aa66f4ff565b44b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Promoter Regions, Genetic
70 rdf:type schema:DefinedTerm
71 N418e61a270194e57a07e1725017c0e28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Humans
73 rdf:type schema:DefinedTerm
74 N41c83773148b48389ed1bfa2f5a615cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Glioma
76 rdf:type schema:DefinedTerm
77 N46f478dd03cf40a989a67bc17cbdbcda schema:volumeNumber 16
78 rdf:type schema:PublicationVolume
79 N4d80f5baa3ef441282b3a4c491d2f895 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Transcription Factor DP1
81 rdf:type schema:DefinedTerm
82 N5231231e32e242889fd6f3a338dae72d schema:name nlm_unique_id
83 schema:value 8711562
84 rdf:type schema:PropertyValue
85 N53171f0c81814ad9a6e667c6f7a274f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name S Phase
87 rdf:type schema:DefinedTerm
88 N5eaa8c60e8ab4b73b4b5381917d46d49 schema:name doi
89 schema:value 10.1038/sj.onc.1201667
90 rdf:type schema:PropertyValue
91 N5f65e69ab18e41ca807ee21d80484e71 schema:name readcube_id
92 schema:value a28c1fc673693cfc0c6a9d795dbe405baf6e925e80d98669434a17bbb9b38efa
93 rdf:type schema:PropertyValue
94 N626ddd66ff17480a9d1478340aa509d5 rdf:first sg:person.01135201435.94
95 rdf:rest rdf:nil
96 N81e95fd87b744da998938904f1cf712b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Enzyme Inhibitors
98 rdf:type schema:DefinedTerm
99 N893880fb3caa46d4bf97a813cf921577 schema:issueNumber 12
100 rdf:type schema:PublicationIssue
101 N897ded43a2c14da8a07252078bc254a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Cell Cycle Proteins
103 rdf:type schema:DefinedTerm
104 N8d8a02b107724b2fab626d9b5ab94739 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Binding Sites
106 rdf:type schema:DefinedTerm
107 Na24f7a8b3ec64c768966fb0fc6848a28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Mice
109 rdf:type schema:DefinedTerm
110 Na67e758bf5c745c0b330d20c6b5028f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name E2F Transcription Factors
112 rdf:type schema:DefinedTerm
113 Nae992ce53cc94381a73ac4209704ebae rdf:first sg:person.0743765737.26
114 rdf:rest N626ddd66ff17480a9d1478340aa509d5
115 Nb0fec11d379642148434b94118f39915 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name G1 Phase
117 rdf:type schema:DefinedTerm
118 Nb3d15c434b114d499f491d1aae0f52a1 rdf:first sg:person.0752637635.21
119 rdf:rest Nae992ce53cc94381a73ac4209704ebae
120 Nb561ace6fcb24e10bce5f4f762571664 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name E2F4 Transcription Factor
122 rdf:type schema:DefinedTerm
123 Nc04627175af54d66938c8d071c2b2a0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Retinoblastoma-Binding Protein 1
125 rdf:type schema:DefinedTerm
126 Nc656112d19c64e7ab9cd2ebc93045a24 schema:name dimensions_id
127 schema:value pub.1034122147
128 rdf:type schema:PropertyValue
129 Nce31583126414be1bca9217afe08219d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name DNA-Binding Proteins
131 rdf:type schema:DefinedTerm
132 Nd7d9537aebaa4f569172545081926da3 schema:name Springer Nature - SN SciGraph project
133 rdf:type schema:Organization
134 Ndfa72609c77748b9989bf4e5735afca0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Cell Cycle
136 rdf:type schema:DefinedTerm
137 Ne04de28244454597bd06475be53a935c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Carrier Proteins
139 rdf:type schema:DefinedTerm
140 Ne61ff0e05e5848b096dc1cf3661530e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Gene Expression Regulation, Neoplastic
142 rdf:type schema:DefinedTerm
143 Ne900918f85c54389a0de30d361f1b240 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Cyclins
145 rdf:type schema:DefinedTerm
146 Ne9826132589c4e2097cba73363f4a8a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Cyclin-Dependent Kinase Inhibitor p21
148 rdf:type schema:DefinedTerm
149 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
150 schema:name Biological Sciences
151 rdf:type schema:DefinedTerm
152 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
153 schema:name Biochemistry and Cell Biology
154 rdf:type schema:DefinedTerm
155 sg:journal.1097543 schema:issn 0950-9232
156 1476-5594
157 schema:name Oncogene
158 rdf:type schema:Periodical
159 sg:person.01135201435.94 schema:affiliation https://www.grid.ac/institutes/grid.38142.3c
160 schema:familyName Reeves
161 schema:givenName Steven A
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135201435.94
163 rdf:type schema:Person
164 sg:person.0743765737.26 schema:affiliation https://www.grid.ac/institutes/grid.51462.34
165 schema:familyName Iavarone
166 schema:givenName Antonio
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743765737.26
168 rdf:type schema:Person
169 sg:person.0752637635.21 schema:affiliation https://www.grid.ac/institutes/grid.38142.3c
170 schema:familyName Hiyama
171 schema:givenName Hirofumi
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752637635.21
173 rdf:type schema:Person
174 https://doi.org/10.1016/b978-0-444-81382-4.50019-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035931085
175 rdf:type schema:CreativeWork
176 https://www.grid.ac/institutes/grid.38142.3c schema:alternateName Harvard University
177 schema:name Molecular Neuro-Oncology, Neuroscience Center, Neurosurgical Services, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02129, USA
178 rdf:type schema:Organization
179 https://www.grid.ac/institutes/grid.51462.34 schema:alternateName Memorial Sloan Kettering Cancer Center
180 schema:name Cell Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, NY, New York 10021, USA
181 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...